Opendata, web and dolomites

ADiRaS

Alzheimer’s Disease Diagnosis by Spectroscopy. Accurate and Non-Invasive Medical Device for the Diagnosis of Early Stage Alzheimer's Disease.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ADiRaS project word cloud

Explore the words cloud of the ADiRaS project. It provides you a very rough idea of what is the project "ADiRaS" about.

accurate    infections    received    65    canal    healthcare    procedure    device    severe    headaches    diagnosis    pet    huge    emission    ht    price    multiple    positron    alzheimer    medical    marker    raman    population    lacks    50    patients    blood    screening    spectroscopy    spinal    cerebrospinal    rs    net    absolutely    first    1500    selling    analyzes    institutionalization    onto    performing    time    plasma    bleeding    numbness    aging    life    admission    2050    saving    company    brain    scans    nursery    400    improves    allergic    people    8bn    fluid    techniques    radioactive    delaying    solution    consists    temporary    revolutionary    expensive    million    living    diagnose    injected    tomography    patient    quality    affordable    expert    reference    lumbar    suffer    total    reactions    relatively    disease    pain    ad    earlier    symptoms    invasive    market    proper    puncture    ameliorating    diagnostic    treatment    legs   

Project "ADiRaS" data sheet

The following table provides information about the project.

Coordinator
RAMAN HEALTH TECHNOLOGIES SL 

Organization address
address: AVDA FRANCISCO VALLES 8 BIOINCUBADORA PARQUE TECNOLOGICO
city: BOECILLO VALLADOLID
postcode: 47151
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RAMAN HEALTH TECHNOLOGIES SL ES (BOECILLO VALLADOLID) coordinator 50˙000.00

Map

 Project objective

Raman HT is a company expert on Raman Spectroscopy (RS) which has developed a revolutionary medical device to diagnose Alzheimer’s Disease (AD) in blood plasma for the first time. Currently, there are only two accurate methods to diagnose AD, expensive, invasive with multiple side effects. Positron Emission Tomography (PET) scans the patient’s brain after being injected with a radioactive marker (cost of €1500) which can cause major allergic reactions. The other method analyzes the cerebrospinal fluid, which requires performing the patient a lumbar puncture. This procedure (relatively expensive, €400) can cause severe headaches, temporary pain of numbness to legs, infections and bleeding into the spinal canal.

There are more than 30 million people living with AD in Europe and more than 7 million people that have not received a diagnostic due to the cost and side effects of the current techniques. Without diagnostic, patients lacks of a proper treatment that improves patients life quality ameliorating the symptoms of the disease. The earlier the diagnosis, the earlier the treatment delaying nursery admission.

Our solution consists of performing RS onto a sample of blood plasma. It is not invasive, has absolutely no side effects and an estimated selling price of €100. Our solution, making AD diagnosis more affordable, can produce net saving of €2,8bn to the European Healthcare system only delaying institutionalization. Our aim is to bring our solution into the market as a reference diagnostic method for screening patients for Alzheimer’s Disease. Alzheimer Disease is a huge problem that Europe needs to address due to the aging population. By 2050, 50% of the total European population will be over 65 years old and more importantly, 1 out 3 will suffer from Alzheimer’s Disease.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ADIRAS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ADIRAS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More  

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More